Paths of Progress 2022
A selection of articles created for this year's Paths of Progress magazine.
To see the entire publication, which includes Dana-Farber's 2021 Annual Report, please download the PDF version.
Articles
Targeting Cancer Cells With Radiopharmaceuticals
These targeted radioactive drugs combine the power of pinpoint accuracy with the benefits of conventional radiation therapy.
Gut Instincts: Mapping the Intestinal Microbiome for Clues About Cancer
The intestinal microbiome is one of the most diverse collections of microorganisms on the planet. Does it hold any clues to cancer?
The Enduring Legacy of David Livingston, MD
A titan among the giants of cancer research, David Livingston, MD, left a legacy of groundbreaking insights into cancer when he died unexpectedly in late 2021.
Making Progress Against Graft-Versus-Host Disease
Dana-Farber scientists help lead the worldwide effort to end the most common side effect of stem-cell transplant.
Request a Publication
Receive by mail the current issue of a Dana-Farber publication by completing this request form.
Media Contacts
If you are a journalist and have a question about any of our stories or need more information, email media@dfci.harvard.edu or call 617-632-4090 and ask to speak to a member of the media team.
The Media Team cannot respond to patient inquiries. For more information on contacting Dana-Farber, please see Contact Us.